Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Feb 23, 2021 3:58pm
151 Views
Post# 32639323

RE:RE:RE:RE:RE:RE:News release!

RE:RE:RE:RE:RE:RE:News release!How does one go about determining a fair rate of return from a life-saving treatment? A lot of money needs to be recouped from researching and developing the treatment and shareholders need to be compensated for their investment, otherwise why would anyone invest? Or develop treatments? On the other hand, gouging the sick to line your pockets is not acceptable. The original figure of $50,000 from Roger White was based on what it was thought patients would be willing to pay. How do you determine a fair price?

CAinPlap wrote: I guess CFO of a biotech is not in my future. I could not in good conscience charge someone a quarter million to stay alive just because that is the going rate or "because I can".

So are we dealing with profit takers or shorters/manipulators causing the drop today?


<< Previous
Bullboard Posts
Next >>